Research Corporation Technologies
VC Fund
Tucson, United States
Research Corporation Technologies is a VC fund in Tucson focused on Biotechnology and Health Care. Ogechison Ventures is a company that was founded by youths after leaving college to engage themselves in research as a form of giving back to the community. The Company also engages in community education projects in a bid to improve education standards in poverty stricken areas
- Total investments:
- 29
- Last investment:
- Lead investor:
- 45%
Last updated:
For AI agents: llms.txt
Industries Research Corporation Technologies invests in
Stages Research Corporation Technologies invests in
Countries Research Corporation Technologies invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biotechnology 11 (38%)
- Health Care 9 (31%)
- Medical Device 7 (24%)
- Medical 6 (21%)
- Pharmaceutical 6 (21%)
Stage
- Series A 7 (24%)
- Series C 6 (21%)
- Series B 5 (17%)
- Funding Round 4 (14%)
- Seed 1 (3%)
Country
- United States 18 (62%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Christopher Martin
Sr. Vice President & CFO
|
Sr. Vice President & CFO | Total investments: 0 | Find email | |
John Roop
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Chad Souvignier
Vice President
|
Vice President | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Codis
|
Codis is a contract development and manufacturing organization (CDMO) specializing in commercial spray drying drying and particle engineering for enhanced bioavailability, high-performance materials, and pharmaceutical supply. | Private Equity / Oct 16, 2025 | |
Pheon Therapeutics
|
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England. | $120M / Series B / May 21, 2024 | |
S2 Genomics
|
S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications. It enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. The company's vision is to provide products that process raw tissues into samples ready for genomicanalyses.S2 Genomics was founded in 2016 and is headquartered in Livermore, CA. | $16M / Series A / Jan 23, 2024 | |
iotaMotion
|
IotaMotion standardizes cochlear implant insertion expanding access to cochlear interventions for surgeons and patients. Its open-platform robotic-assisted system aims to decrease surgical variability by controlling the speed and acceleration of electrode insertion. | $12M / Series A / Jul 26, 2023 | |
|
Pheon Therapeutics
|
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England. | $68M / Series A / Sep 28, 2022 | |
Halo Labs
|
Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics.Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced ResearchProjects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.The company was founded in 2011 and headquartered in Pennsylvania, United States. | $7M / Series C / Jul 08, 2022 | |
seqWell
|
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory services. It features a technology platform that serves as a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization.The company was foundedin 2014 and headquartered in Massachusetts, United States. | $7M / Series C / Mar 29, 2022 | |
|
Pheon Therapeutics
|
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England. | Seed / Jan 01, 2022 | |
Q'Apel Medical
|
Q'Apel Medical designs access device technology for neurovascular interventions and unmet clinical needs. The company was founded in 2016 and is headquartered in Fremont, California. | $22M / Series C / Feb 11, 2021 | |
|
Halo Labs
|
Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics.Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced ResearchProjects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.The company was founded in 2011 and headquartered in Pennsylvania, United States. | $12M / Series B / Apr 06, 2020 | |
| See all 29 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Research Corporation Technologies invest in?
Research Corporation Technologies invests primarily in Biotechnology, Health Care and Medical Device startups, most often at Series A and Series C stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Research Corporation Technologies?
Public channels for Research Corporation Technologies include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Research Corporation Technologies?
The team at Research Corporation Technologies includes Christopher Martin (Sr. Vice President & CFO), John Roop (Managing Director) and Chad Souvignier (Vice President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
